This comprehensive report predicts that the global E. coli testing market is set to grow at a CAGR of 5.81% during the period 2016-2020.

Commenting on the report, an analyst from the research team said: Increasing adoption of multiplex PCR technology is the current trend in the market. Multiplexing is a method used to detect two or more analytes simultaneously in a single sample. This method is currently integrated with different IVD methods, including immunoassay-, clinical chemistry-, and nucleic acid-based diagnostics. Multiplexing increases the accuracy by limiting the variations during the testing, also many samples can be analyzed at the same time. It reduces the cost and time consumed for specific diagnosis of infectious agents.

Further, the report states that Currently, PCR is a popular method of testing for the diagnosis of different diseases in a clinical setting. However, it has certain limitations. This method is not useful in predicting the viability of the pathogen linked to the disease, and, therefore, could yield a false positive outcome.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Questions Answered:

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the strengths and weaknesses of the key vendors?

Companies Mentioned:

Alere

Becton

Dickinson and Company (BD)

bioMérieux

Meridian Bioscience

Accugen Laboratories

Bio-Rad Laboratories

Diasorin

EIKEN CHEMICAL

Enzo Life Sciences

InstantLabs

Luminex Corporation

Mobidiag

Nanosphere

Pro-Lab Diagnostics

QIAGEN

Rome

Report Structure:

PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Reimbursement and coverage: An overview
PART 07: Market segmentation by product
PART 08: Technology platforms for E. coli testing
PART 09: Geographical segmentation
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
PART 16: Appendix
PART 17: About Author